Genmab A/SGMABNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P33
Within normal range
vs 5Y Ago
-5.9x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -50.77% |
| Q3 2025 | -81.13% |
| Q2 2025 | 1025.82% |
| Q1 2025 | -94.89% |
| Q4 2024 | 207.18% |
| Q3 2024 | -10.09% |
| Q2 2024 | 6.90% |
| Q1 2024 | 107.14% |
| Q4 2023 | -69.94% |
| Q3 2023 | 56.73% |
| Q2 2023 | 550.00% |
| Q1 2023 | -64.44% |
| Q4 2022 | -77.27% |
| Q3 2022 | 37.02% |
| Q2 2022 | 307.04% |
| Q1 2022 | -35.45% |
| Q4 2021 | -19.12% |
| Q3 2021 | 189.36% |
| Q2 2021 | -72.02% |
| Q1 2021 | 90.91% |
| Q4 2020 | 8.64% |
| Q3 2020 | -84.39% |
| Q2 2020 | 1165.85% |
| Q1 2020 | -82.40% |
| Q4 2019 | 177.38% |
| Q3 2019 | 500.00% |
| Q2 2019 | 16.67% |
| Q1 2019 | -91.18% |
| Q4 2018 | 368.97% |
| Q3 2018 | -32.56% |
| Q2 2018 | 30.30% |
| Q1 2018 | -74.42% |
| Q4 2017 | 14433.33% |
| Q3 2017 | -101.76% |
| Q2 2017 | 1788.89% |
| Q1 2017 | -98.09% |
| Q4 2016 | 340.62% |
| Q3 2016 | 14.29% |
| Q2 2016 | 1573.68% |
| Q1 2016 | -102.84% |